Embla Medical hf. (CPH:EMBLA)
32.60
-0.30 (-0.91%)
At close: Feb 21, 2025
Embla Medical Revenue
In the year 2024, Embla Medical had annual revenue of $854.89M USD with 8.81% growth. Embla Medical had revenue of $224.78M in the quarter ending December 31, 2024, with 6.94% growth.
Revenue
$854.89M
Revenue Growth
+8.81%
P/S Ratio
2.26
Revenue / Employee
$210.51K
Employees
4,061
Market Cap
13.92B DKK
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 854.89M | 69.21M | 8.81% |
Dec 31, 2023 | 785.68M | 67.03M | 9.33% |
Dec 31, 2022 | 718.65M | -19.00K | -0.00% |
Dec 31, 2021 | 718.67M | 89.17M | 14.16% |
Dec 31, 2020 | 629.50M | -56.76M | -8.27% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 290.40B |
Coloplast | 27.45B |
Genmab | 21.53B |
Demant | 22.42B |
Zealand Pharma | 62.69M |
H. Lundbeck | 22.00B |
Ambu A/S | 5.65B |
ALK-Abelló | 5.54B |